Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.

作者: V. Poli , R. Balena , E. Fattori , A. Markatos , M. Yamamoto

DOI: 10.1002/J.1460-2075.1994.TB06368.X

关键词:

摘要: Interleukin-6 (IL-6) is a multifunctional cytokine whose circulating levels are under physiological conditions below detection, but production rapidly and strongly induced by several pathological inflammatory stimuli. IL-6 has been implicated in number of cell functions connected to immunity hematopoiesis. Recently, it proposed act as stimulator osteoclast formation activity, particular following estrogen depletion. The purpose this study was gain additional insights into the role during development, well conditions. We report here that deficient mice generated gene targeting viable do not present any evident phenotypic abnormality. However, analysis bone metabolism revealed specific phenotype. female have normal amount trabecular bone, higher rates turnover than control littermates. Estrogen deficiency ovariectomy causes wild type animals significant loss mass together with an increase rates. Strikingly, does induce change either or remodeling mice. These findings indicate plays important local regulation and, at least mice, appears be essential for caused deficiency.

参考文章(32)
S Akira, T Hirano, T Kamiya, T Kishimoto, G G Wong, O Tanabe, Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human. Journal of Immunology. ,vol. 141, pp. 3875- 3881 ,(1988)
Tetsuya Taga, Tadamitsu Kishimoto, Cytokine receptors and signal transduction. The FASEB Journal. ,vol. 6, pp. 3387- 3396 ,(1992) , 10.1096/FASEBJ.6.15.1334470
G Ciliberto, S Oliviero, R Arcone, L Dente, J Content, R Cortese, G Morrone, Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. Journal of Biological Chemistry. ,vol. 263, pp. 12554- 12558 ,(1988) , 10.1016/S0021-9258(18)37790-1
A Yamaguchi, T Akatsu, T Matsuda, T Hirano, S Yoshiki, C Miyaura, E Abe, Y Nakamura, C H Jin, Y Ishimi, IL-6 is produced by osteoblasts and induces bone resorption. Journal of Immunology. ,vol. 145, pp. 3297- 3303 ,(1990)
Toshio Hirano, Shizuo Akira, Tetsuya Taga, Tadamitsu Kishimoto, Biological and clinical aspects of interleukin 6 Immunology Today. ,vol. 11, pp. 443- 449 ,(1990) , 10.1016/0167-5699(90)90173-7
M. Horowitz, Cytokines and estrogen in bone: anti-osteoporotic effects Science. ,vol. 260, pp. 626- 627 ,(1993) , 10.1126/SCIENCE.8480174
Kirk R. Thomas, Mario R. Capecchi, Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells Cell. ,vol. 51, pp. 503- 512 ,(1987) , 10.1016/0092-8674(87)90646-5
Colin L. Stewart, Petr Kaspar, Lisa J. Brunet, Harshida Bhatt, Inder Gadi, Frank Köntgen, Susan J. Abbondanzo, Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature. ,vol. 359, pp. 76- 79 ,(1992) , 10.1038/359076A0
R. Jilka, G Hangoc, G Girasole, G Passeri, D. Williams, J. Abrams, B Boyce, H Broxmeyer, S. Manolagas, Increased osteoclast development after estrogen loss: mediation by interleukin-6 Science. ,vol. 257, pp. 88- 91 ,(1992) , 10.1126/SCIENCE.1621100
W. Wiktor-Jedrzejczak, A. Bartocci, A. W. Ferrante, A. Ahmed-Ansari, K. W. Sell, J. W. Pollard, E. R. Stanley, Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 4828- 4832 ,(1990) , 10.1073/PNAS.87.12.4828